INS and preeclampsia: More recently, Cosson et al. [31] reported that women who received initial care vs. those who did not, were more likely to be insulin-treated during pregnancy (58.0% vs. 20.9%, respectively; p < 0.00001), gained less gestational weight (8.6 ± 5.4 kg vs. 10.8 ± 6.1 kg, respectively; p < 0.00001), had a lower rate of preeclampsia (1.2% vs. 2.6%, respectively; adjusted odds ratio (aOR): 0.247 (0.082–0.759), p = 0.01), and similar rates of LGA infants and shoulder dystocia.